Oncopeptides Ab Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ONCOPEPTIDES AB, and what generic alternatives to ONCOPEPTIDES AB drugs are available?
ONCOPEPTIDES AB has one approved drug.
There are five US patents protecting ONCOPEPTIDES AB drugs.
There are seventy-six patent family members on ONCOPEPTIDES AB drugs in twenty-seven countries.
Drugs and US Patents for Oncopeptides Ab
International Patents for Oncopeptides Ab Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Serbia | 60719 | See Plans and Pricing |
Japan | 4798930 | See Plans and Pricing |
Hungary | E051690 | See Plans and Pricing |
China | 103547279 | See Plans and Pricing |
Spain | 2768268 | See Plans and Pricing |
Israel | 280812 | See Plans and Pricing |
Australia | 2012247545 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.